SWOT Analysis for Novartis India Ltd.

Add SWOT widget to your site/app

Companies with no Debt
Benjamin Graham Value Screen
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Mid-range Performer (DVM)
PEG lower than Industry PEG
Effectively using its capital to generate profit - RoCE improving in last 2 years
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Zero Promoter Pledge
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Decrease in Provision in recent results
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter

Companies with no Debt

Benjamin Graham Value Screen

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Mid-range Performer (DVM)

PEG lower than Industry PEG

Effectively using its capital to generate profit - RoCE improving in last 2 years

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Decrease in Provision in recent results

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)
Stocks in downtrend most likely to cross below SMA-200 soon
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Declining Net Cash Flow : Companies not able to generate net cash
RSI indicating price weakness
Top Losers

Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)

Stocks in downtrend most likely to cross below SMA-200 soon

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

RSI indicating price weakness

Top Losers

Mutual Funds Increased Shareholding over the Past Two Months

Mutual Funds Increased Shareholding over the Past Two Months

Red Flags: Weakening Technicals and Share Price Decline

Red Flags: Weakening Technicals and Share Price Decline

High Piotroski Score - Companies with strong financials
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)

High Piotroski Score - Companies with strong financials

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)

Novartis India Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Novartis India Ltd. has 12 Strengths, 6 Weaknesses, 1 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Companies with no Debt

Benjamin Graham Value Screen

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Mid-range Performer (DVM)

PEG lower than Industry PEG

Effectively using its capital to generate profit - RoCE improving in last 2 years

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Decrease in Provision in recent results

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)

Stocks in downtrend most likely to cross below SMA-200 soon

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

RSI indicating price weakness

Top Losers

Mutual Funds Increased Shareholding over the Past Two Months

Red Flags: Weakening Technicals and Share Price Decline

High Piotroski Score - Companies with strong financials

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)